A Study of Vemurafenib and Obinutuzumab Compared to Cladribine and Rituximab in People With Hairy Cell Leukemia (HCL)
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
Scripps Health
University of Giessen
Barbara Ann Karmanos Cancer Institute
Wake Forest University Health Sciences
Fred Hutchinson Cancer Center
Masonic Cancer Center, University of Minnesota
Fred Hutchinson Cancer Center
Mayo Clinic
Rutgers, The State University of New Jersey
Swiss Cancer Institute